The field of oncology is leading the precision medicine revolution. Heidelberg and Leuven, as two major players in the field world-wide, jointly organize an International Visionary Seminar on the topic.

The event covers some of the most promising novel approaches in research from Flemish and German academia and industry. What are the most important breakthroughs we can expect?

Meanwhile, the advancement of precision medicine into routine clinical practice is hindered by the process in meeting requirements of the payer or reimbursement agency for health care.

Eminent speakers will discuss reimbursement challenges and policies and cost-based pricing versus value-based pricing from a pharma, payer and molecular diagnostics perspective.

More information and agenda here.

Confirmed Speakers

• Frank Ulrich Montgomery, President of the German Medical Association

• Andree Blaukat, Merck

• Michel Delforge, Leuven Cancer Institute

• Katelijne De Nys, Belgian Commission for the Reimbursement of Medicines

• Liesbet Lagae, Program Director Life Science Technologies at IMEC

• Diether Lambrechts, VIB-KU Leuven Center for Cancer Biology

• Michael Schlander, German Cancer Research Center

• Özlem Türeci, Ci3 e.V. and Ganymed

• Olaf Witt, Hopp Children’s Cancer Center at the NCT (KiTZ)

Download the programme.

Location

Auditorium – University Hospital Heidelberg – Center for Internal Medicine (Neue Krehl Klinik). Im Neuenheimer Feld 410, Heidelberg.

The Health Axis Europe Visionary Seminar is organised by the BioRN Cluster with SMART HUB Flemish Brabant